Digital Pathology Market

The global digital pathology market was estimated to be US$ 915.54 million in 2022 and is expected to reach US$ 1,964.24 million by 2032 at a CAGR of 8.08%.

Digital pathology is the most nascent and emerging technology in the pathology sector. In the current methodology, the glass slides that consist of specimen samples are transformed into digital images for easy storage, observance, analysis, and management of the gathered data. This is empowered in part owing to virtual microscopy that is a technology that helps in popular image posting and transmission over a connected network.

The data-rich image forms the base for electronic health records maintenance of the patient population and thus compiles the distributed information in order to build up a central database. The technological advancements in digital pathology is anticipated to overtake the traditional pathology to an advanced level.

Digitalization of pathology has resulted in the tests automation during diagnosis, thereby saving cost as well as efforts. For instance, a single digital instrument can conduct the tests that were previously conducted using five instruments by pathologists.

Segmentation of Global Digital Pathology Market

The global digital pathology market is segmented on the basis of product, type, end-users and application. By product, the market is classified into scanners, software, communication system and storage systems. Depending on type, the global digital pathology market is classified into human and animal pathology. Based on end-users, the global digital pathology market is divided into pharmaceutical, hospitals and academic agencies. Based on application, the market is subdivided into drug discovery; and teleconsultation. Digital pathology plays a vital role in companion diagnostics as well as drug development pipeline that includes molecular tissue profiling, molecular biology, biobanking, and tissue microarray analysis. An increase in demand for high-quality tissue samples in tissue-based biomarker research is fuelling the increased rate of adoption of this technology during the forecast period.

The global digital pathology market is set to register an intense competition in the future owing to increase in the rate of adoption of rigorous strategies by the market players in order to retain competition. Based on regions, the global digital pathology market is divided into North America, Europe, Asia-Pacific (APAC), Middle East & Africa (MEA), and Latin America. The North American region is anticipated to command the maximum market share and would lead the digital pathology market during the forecast period.

Factors such as the rise in chronic disease prevalence and increased number of initiatives by major industry players and government in diagnostics sector are propelling the digital pathology market growth. However, the Asia-Pacific region is expected to exhibit highest growth rate during the future period.

The major companies that provide digital pathology include Hamamatsu Photonics K.K, Leica Biosystems Nussloch GmbH, Definiens AG, Corista LLC, 3D Histech Ltd, Philips Healthcare, Apollo Enterprise Imaging Corp., Xifin, Inc., Visiopharm A/S, Ventana Medical Systems, Inc., Omnyx, LLC., among others.

Global Digital Pathology Market Segmentation:

By Product

• scanners
• software
• communication system
• storage systems

By Type

• human pathology
• animal pathology

By End-User

• pharmaceutical
• hospitals
• academic agencies

By Application

• drug discovery
• teleconsultation

By Geography

• North America
• Europe
• Asia Pacific
• Middle East & Africa
• South America